Horizon Therapeutics: Q1 Earnings Insights

Horizon Therapeutics HZNP reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Horizon Therapeutics beat estimated earnings by 11.67%, reporting an EPS of $1.34 versus an estimate of $1.2.

Revenue was up $542.84 million from the same period last year.

Last quarter the company beat on EPS by $0.07 which was followed by a 1.28% increase in the share price the next day.

Here's a look at Horizon Therapeutics's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	1.34	1.54	0.88	0.04
EPS Actual	1.41	1.75	1.62	0.03
Revenue Estimate	995.87M	979.41M	685.03M	330.73M
Revenue Actual	1.01B	1.04B	832.55M	342.41M

To track all earnings releases for Horizon Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.